Literature DB >> 27378586

Dermoscopy and direct immunofluorescence findings of elastosis perforans serpiginosa.

J L Ramírez-Bellver1, C Bernárdez1, E Macías1, L Moya1, A M Molina-Ruiz1, P Cannata Ortiz2, L Requena2.   

Abstract

Elastosis perforans serpiginosa (EPS) is a rare skin disorder characterized by transepidermal elimination of abnormal elastic fibres. We present a new case of D-penicillamine (DPA)-induced EPS, and describe the clinical, dermoscopic, histopathological and direct immunofluorescence (DIF) findings. A 33-year-old woman receiving treatment with DPA presented with annular skin lesions. Digital dermoscopy of the lesions showed a central area of pink and yellowish discolouration with keratotic papules in the periphery, surrounded by a white halo, disposed in a way that resembled the islands of an archipelago. Other lesions showed a white to yellow central colouration and 'chrysalides' surrounding the keratotic plugs. Linear and granular deposits of IgG attached to the abnormal elastic fibres were seen with DIF. Dermoscopy can be helpful in the diagnosis of EPS. Moreover, DIF findings in skin biopsies of this case support the immune-mediated pathogenesis of EPS.
© 2016 British Association of Dermatologists.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27378586     DOI: 10.1111/ced.12882

Source DB:  PubMed          Journal:  Clin Exp Dermatol        ISSN: 0307-6938            Impact factor:   3.470


  3 in total

Review 1.  Utility of immunofluorescence in dermatology.

Authors:  Varsha M Shetty; Kumudhini Subramaniam; Raghavendra Rao
Journal:  Indian Dermatol Online J       Date:  2017 Jan-Feb

2.  Elastosis Perforans Serpiginosa: a D-penicillamine induced dermatoses in a patient with Wilson's disease.

Authors:  Swagatika Samal; Mukund Sable
Journal:  Autops Case Rep       Date:  2020-05-06

3.  Dermoscopic pattern of Kyrle's disease.

Authors:  Ozlem Ozbagcivan; Banu Lebe; Emel Fetil
Journal:  An Bras Dermatol       Date:  2020-02-12       Impact factor: 1.896

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.